Condition category
Signs and Symptoms
Date applied
06/11/2002
Date assigned
06/11/2002
Last edited
11/04/2008
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr Atle Fretheim

ORCID ID

Contact details

Department of Health Services Research
Norwegian Directorate of Health and Social Welfare
PO Box 8054 Dep
Oslo
N-0031
Norway
+47 24 16 32 96
Atle.fretheim@shdir.no

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

HF-004

Study information

Scientific title

Acronym

RaPP

Study hypothesis

To evaluate the effects of a tailored intervention to support the implementation of systematically developed guidelines for the use of antihypertensive and cholesterol-lowering drugs for the primary prevention of cardiovascular disease.

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

GP practices

Trial type

Diagnostic

Patient information sheet

Condition

Hypertension and hyperlipidaemia

Intervention

Tailor-made intervention (outreach visit, audit & feedback, computerised reminders) versus passive distribution of guidelines

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Not provided at time of registration

Secondary outcome measures

Not provided at time of registration

Overall trial start date

01/01/2001

Overall trial end date

01/01/2002

Reason abandoned

Eligibility

Participant inclusion criteria

Primary care practices in two parts of Norway.

Participant type

Patient

Age group

Not Specified

Gender

Not Specified

Target number of participants

146 general practices

Participant exclusion criteria

Not provided at time of registration

Recruitment start date

01/01/2001

Recruitment end date

01/01/2002

Locations

Countries of recruitment

Norway

Trial participating centre

Department of Health Services Research
Oslo
N-0031
Norway

Sponsor information

Organisation

Norwegian Directorate of Health and Social Welfare (Norway)

Sponsor details

Post box 8054 Dep
Oslo
N-0031
Norway
+47 22 24 65 00
post@rusdir.no

Sponsor type

Government

Website

Funders

Funder type

Government

Funder name

Norwegian Ministry of Health (Norway)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

1. Protocol in http://www.ncbi.nlm.nih.gov/pubmed/12657163
2. Results in http://www.ncbi.nlm.nih.gov/pubmed/16737346

Publication citations

  1. Protocol

    Fretheim A, Oxman AD, Treweek S, Bjørndal A, Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230]., BMC Health Serv Res, 2003, 3, 1, 5.

  2. Results

    Fretheim A, Oxman AD, Håvelsrud K, Treweek S, Kristoffersen DT, Bjørndal A, Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention., PLoS Med., 2006, 3, 6, e134, doi: 10.1371/journal.pmed.0030134.

Additional files

Editorial Notes